Evidence map›Paper›PMID 35566438›Full record

ReviewJournal of clinical medicine2022

Surgical Treatment in Hidradenitis Suppurativa.

Ratnakar Shukla, Priyanka Karagaiah, Anant Patil, Katherine Farnbach, Alex G Ortega-Loayza, Thrasivoulos Tzellos, Jacek C Szepietowski, Mario Giulini, Hadrian Schepler, Stephan Grabbe and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 5 countries.

Ratnakar ShuklaDepartment of Dermatology, All India Institute of Medical Sciences Gorakhpur (AIIMS), Gorakhpur 273008, India.
Priyanka KaragaiahDepartment of Dermatology, Bangalore Medical College and Research Institute, Bangalore 560002, India.
Anant PatilDepartment of Pharmacology, Dr. DY Patil Medical College, Navi Mumbai 400706, India.ORCID 0000-0002-9455-4025
Katherine FarnbachDepartment of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
Alex G Ortega-LoayzaDepartment of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
Thrasivoulos TzellosDepartment of Dermatology, NLSH University Hospital, 8092 Bodø, Norway.
Jacek C SzepietowskiDepartment of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-367 Wroclaw, Poland.ORCID 0000-0003-0766-6342
Mario GiuliniDepartment of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
Hadrian ScheplerDepartment of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
Stephan GrabbeDepartment of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.ORCID 0000-0002-6863-8719
Mohamad GoldustDepartment of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.ORCID 0000-0002-8646-1179
Johannes Gutenberg University Mainz · DEOregon Health & Science University · USAll India Institute of Medical Sciences Raipur · INBangalore Medical College and Research Institute · INDr. D. Y. Patil Medical College, Hospital and Research Centre · INNordland Hospital · NOWroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hidradenitis suppurativa (HS) is a chronic, progressive inflammatory disorder of follicular occlusion with pubertal onset that presents as painful inflammatory nodules, sinus tracts, and tunnelling in apocrine-gland-rich areas, such as the axilla, groin, lower back, and buttocks. The disease course is complicated by contractures, keloids, and immobility and is often associated with a low quality of life. It is considered a disorder of follicular occlusion with secondary inflammation, though the exact cause is not known. Management can often be unsatisfactory and challenging due to the chronic nature of the disease and its adverse impact on the quality of life. A multidisciplinary approach is key to prompt optimal disease control. The early stages can be managed with medical treatment, but the advanced stages most likely require surgical intervention. Various surgical options are available, depending upon disease severity and patient preference. In this review an evidence-based outline of surgical options for the treatment of HS are discussed. Case reports, case series, cohort studies, case-control studies, and Randomized Clinical Trials (RCT)s available in medical databases regarding surgical options used in the treatment of HS were considered for the review presented in a narrative manner in this article.

Indexed as

apocrine glandfollicular occlusionhidradenitis suppurativa

Identifiers

PMID35566438
PMCPMC9101712
OpenAlexW4226494282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.